FXTAS
Emmanuelle Apartis(School of the Art Institute of Chicago), Mathieu Anheim(Centre National de la Recherche Scientifique), Bertrand Gaymard(School of the Art Institute of Chicago), T. de Broucker(School of the Art Institute of Chicago), Valérie Fraix(School of the Art Institute of Chicago), Sandra Whalen(Sorbonne Université), Carole Roué-Jagot(School of the Art Institute of Chicago), Alexandra Dürr(Institut du Cerveau), Alexis Brice(School of the Art Institute of Chicago), Stéphane Thobois(Université Claude Bernard Lyon 1), Marie‐Odile Habert(Centre National de la Recherche Scientifique), Hichem Bouzenada(School of the Art Institute of Chicago), Hung Tran-Thanh(School of the Art Institute of Chicago), Gaëtan Lesca(Hospices Civils de Lyon), Jean‐Claude Dussaule(School of the Art Institute of Chicago), Anne Blancher(School of the Art Institute of Chicago), Alice Poisson(Université Claude Bernard Lyon 1), Perrine Charles(School of the Art Institute of Chicago), David Maltête(Inserm), Wassilios G. Meissner(Centre National de la Recherche Scientifique), François Tison(Institut des Maladies Neurodégénératives), Delphine Héron(Sorbonne Université), Adrien Wang(ASTER), Lucie Guyant‐Maréchal(School of the Art Institute of Chicago), Anne-Marie Ouvrard-Hernandez(School of the Art Institute of Chicago), Jean-Claude Barbot(School of the Art Institute of Chicago), Frédéric Sedel(Sorbonne Université), A. P. Legrand(School of the Art Institute of Chicago), Stéphane Palfi(School of the Art Institute of Chicago), Véronique Gourlet(School of the Art Institute of Chicago), M. Sallansonnet-Froment(School of the Art Institute of Chicago), Pierre Pollak(School of the Art Institute of Chicago), Marie Vidailhet(School of the Art Institute of Chicago)
Cited by 179
Related Papers
Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria
|Movement Disorders|2017|2.3k
The Movement Disorder Society Criteria for the Diagnosis of Multiple System Atrophy
|Movement Disorders|2022|775
The natural history of multiple system atrophy: a prospective European cohort study
|The Lancet Neurology|2013|533
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508
Recommendations for the diagnosis and management of Niemann–Pick disease type C: An update
|Molecular Genetics and Metabolism|2012|478